Boothbay Fund Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Boothbay Fund Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-22,500	Closed	-$3.72M	–	2427
2021 Q2	$3.72M	Buy	+22,500	New	+$3.76M	0.12%	191
2020 Q1	–	Sell	-4,793	Closed	-$533K	–	1173
2019 Q4	$533K	Sell	4,793 -14,289	-75%	-$1.47M	0.05%	473
2019 Q3	$1.89M	Buy	+19,082	New	+$1.89M	0.17%	161

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Boothbay Fund Management's PRAH Position: Q3 2021 in Review

Boothbay Fund Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 22,500 shares — an estimated $3.72M sold.

Boothbay Fund Management first reported a position in PRAH in Q3 2019 and held it in 3 quarters. The position peaked at $3.72M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Boothbay Fund Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Boothbay Fund Management sold 22,500 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $3.72M.
Boothbay Fund Management first reported a position in PRA Health Sciences, Inc. in Q3 2019 and held it in 3 quarters.
Boothbay Fund Management's PRA Health Sciences, Inc. position peaked at $3.72M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.